Insider · CIK 0001296907
Elaine Jones V
Files at CTMX (CytomX Therapeutics, Inc.), GRTS (Gritstone bio, Inc.), NXTC (NextCure, Inc.). First filing -, latest -.
In brief
Elaine Jones V files SEC Form 4 as director at CTMX (CytomX Therapeutics, Inc.), and also at GRTS (Gritstone bio, Inc.), NXTC (NextCure, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Elaine Jones V has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | NXTC NextCure, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,340 | $0.00 | $0 | 2,340 | Jun 22, 2026 |
| Jun 17, 2026 | CTMX CytomX Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +59,000 | $0.00 | $0 | 59,000 | Jun 22, 2026 |
| Jun 20, 2025 | NXTC NextCure, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +18,700 | $0.00 | $0 | 18,700 | Jun 24, 2025 |
| Jun 11, 2025 | CTMX CytomX Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Jun 13, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -51,800 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -51,800 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stcok Option (right to buy)derivative | -19,000 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -19,000 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -12,500 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -15,942 | $0.00 | $0 | 0 | Apr 8, 2025 |
Questions about Elaine Jones V
Answered from the filings on this page, as of the latest one.
Is Elaine Jones V buying or selling?
Elaine Jones V has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Elaine Jones V's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elaine Jones V has 0.
Where does Elaine Jones V file Form 4?
Elaine Jones V has filed Form 4 at CTMX (CytomX Therapeutics, Inc.); GRTS (Gritstone bio, Inc.); NXTC (NextCure, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.